GO:0035701 hematopoietic stem cell migration: Niche Interactions, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035701 (hematopoietic stem cell migration) describes the orderly movement of a hematopoietic stem cell from one site to another, a process essential for seeding fetal and adult blood systems.
• Hematopoietic stem cell (HSC) migration depends on chemokine gradients, adhesion molecules, and extracellular matrix remodeling that together guide cells to and from bone marrow niches.
• The niche, including osteoblastic, endothelial, and perivascular cells, provides signals that retain, mobilize, or direct HSCs during development, homeostasis, and stress.
• Key regulators include CXCR4/CXCL12 signaling, integrins, selectins, matrix metalloproteinases, and transcription factors such as YY1 that control migration and engraftment.
• Defective HSC migration contributes to bone marrow failure, leukemogenesis, and impaired engraftment after transplantation, making it a target for experimental modeling.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of migration-related genes in HSC-like cell lines and primary cells.
Description
Hematopoietic stem cell migration (GO:0035701) is the biological process by which a hematopoietic stem cell moves in an orderly manner from one anatomical site to another. This process is fundamental during embryogenesis, when HSCs arise in the aorta-gonad-mesonephros region and migrate to the fetal liver and later to the bone marrow, and it remains critical throughout adult life for homeostatic trafficking and stress responses. Researchers study this term because defects in HSC migration underlie engraftment failure, bone marrow failure syndromes, and leukemia dissemination. The QuickGO definition emphasizes that a hematopoietic stem cell is a cell from which all lymphoid and myeloid lineages develop, including blood cells and immune cells, making its migration a central event for immune system development and regeneration. Understanding the molecular players that control HSC migration is therefore essential for improving transplantation, mobilizing stem cells for collection, and designing therapies that target leukemic stem cell spread.
hematopoietic stem cell migration At A Glance
| GO ID | GO:0035701 |
|---|---|
| GO term | hematopoietic stem cell migration |
| Ontology | biological_process |
| Synonym | hemopoietic stem cell migration |
| Major function | Orderly movement of hematopoietic stem cells between anatomical sites, including fetal liver, bone marrow, and peripheral blood |
| Cellular context | Hematopoietic stem cells interact with bone marrow niche cells, endothelial cells, and extracellular matrix during migration |
| Key molecular players | CXCR4/CXCL12 axis, integrins, selectins, matrix metalloproteinases, and transcription factors such as YY1 |
| Physiological relevance | Essential for developmental seeding of blood tissues, steady-state trafficking, and stress-induced mobilization |
| Disease relevance | Implicated in engraftment failure, bone marrow failure, and leukemic stem cell dissemination |
What Is GO:0035701?
GO:0035701, hematopoietic stem cell migration, is defined as the orderly movement of a hematopoietic stem cell from one site to another. A hematopoietic stem cell is a cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system. The synonym hemopoietic stem cell migration is also used. This process encompasses directed and random movement components, including chemotaxis, transendothelial migration, and migration through extracellular matrix, and it is distinct from proliferation or differentiation per se.
Why Is hematopoietic stem cell migration Important in Cell Biology?
Hematopoietic stem cell migration is important because it determines where HSCs reside, how they are mobilized, and whether they successfully engraft after transplantation. The process is required for the establishment of the blood system during development and for the continuous supply of immune cells throughout life. In the clinic, understanding HSC migration informs stem cell collection, bone marrow transplantation, and the design of mobilizing agents. Moreover, dysregulated migration can contribute to leukemia progression and bone marrow failure, making this GO term a focal point for both basic and translational research.
• Enables developmental seeding of fetal liver and bone marrow by HSCs.
• Supports steady-state trafficking of HSCs between bone marrow and blood.
• Underlies stress-induced mobilization, such as after chemotherapy or G-CSF treatment.
• Is required for successful engraftment after hematopoietic stem cell transplantation.
• Contributes to immune cell development and maintenance of immunological memory.
• Is dysregulated in leukemias, where leukemic stem cells may exploit migratory pathways.
• Involves niche interactions that can be targeted to improve mobilization protocols.
• Provides a measurable phenotype for CRISPR screens and functional genomics.
• Links extracellular matrix remodeling to stem cell fate decisions.
• Serves as a model for studying cell migration in general, including chemotaxis and transendothelial migration.
What Happens During hematopoietic stem cell migration?
Initiation and chemokine sensing
In simple terms: The stem cell first senses chemical signals that tell it where to go.
HSC migration begins when cells detect chemokine gradients, most notably CXCL12 acting through CXCR4, which is a central axis for HSC retention and migration. Additional signals from the niche, including cytokines and growth factors, modulate the strength and direction of the migratory response. In the absence of proper chemokine sensing, HSCs fail to localize correctly during development and in adult bone marrow.
Adhesion and detachment from the niche
In simple terms: The stem cell must first let go of its anchor in the bone marrow before it can move.
HSCs reside in specialized niches where adhesion molecules such as integrins and selectins tether them to stromal and endothelial cells. Migration requires dynamic regulation of these adhesions, allowing detachment and subsequent movement. Matrix metalloproteinases and other enzymes remodel the extracellular matrix to create paths for migration.
Transendothelial migration and intravasation
In simple terms: The stem cell squeezes through blood vessel walls to enter the bloodstream.
To enter circulation, HSCs undergo transendothelial migration, interacting with endothelial cells lining bone marrow sinusoids. This step involves chemokine presentation by endothelial cells and integrin-mediated adhesion, followed by diapedesis. Endothelial cells actively regulate this process, as shown by studies of the role of endothelium in HSC migration.
Migration through blood and homing to target tissues
In simple terms: Once in the blood, the stem cell travels to a new location and settles there.
After intravasation, HSCs migrate through the bloodstream and home to target tissues such as fetal liver or bone marrow. Homing requires recognition of tissue-specific signals and extravasation at the destination. This step is critical for engraftment after transplantation and for developmental seeding of hematopoietic tissues.
Engraftment and niche re-entry
In simple terms: The stem cell finds a new home and attaches to start producing blood cells.
Upon reaching the target niche, HSCs re-engage adhesion molecules and receive survival and retention signals that allow engraftment. Engraftment is the functional endpoint of successful migration and is measured experimentally by repopulation assays. Transcription factors such as YY1 have been shown to control fetal HSC migration and engraftment in mice.
Key Genes Involved in GO:0035701 hematopoietic stem cell migration
The following genes and proteins are experimentally implicated in hematopoietic stem cell migration and its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCR4 | Chemokine receptor mediating HSC migration and retention in bone marrow | Target for mobilization and engraftment studies |
| CXCL12 | Chemokine ligand that forms gradients guiding HSC migration | Niche-derived signal for HSC localization |
| ITGB1 | Integrin subunit mediating adhesion to extracellular matrix and endothelium | Controls detachment and transendothelial migration |
| ITGA4 | Integrin subunit involved in HSC adhesion and migration | Implicated in homing and engraftment |
| SELL | Selectin ligand mediating rolling on endothelium | Facilitates transendothelial migration |
| MMP2 | Matrix metalloproteinase that remodels extracellular matrix | Enables migration through basement membranes |
| MMP9 | Matrix metalloproteinase involved in niche remodeling and mobilization | Linked to stress-induced mobilization |
| YY1 | Transcription factor controlling fetal HSC migration and engraftment | Demonstrated by knockout studies in mice |
| KIT | Receptor tyrosine kinase responding to stem cell factor | Supports survival and migration signaling |
| CD34 | Surface marker and adhesion molecule on HSCs | Used for isolation and migration assays |
| PECAM1 | Endothelial adhesion molecule at cell junctions | Participates in transendothelial migration |
| VEGFA | Growth factor influencing vascular permeability and HSC trafficking | Modulates niche and migration |
| SDF1 | Alternative name for CXCL12 chemokine | Central to HSC chemotaxis |
| SPI1 | Transcription factor in hematopoietic development | May influence migratory gene programs |
| RUNX1 | Transcription factor required for HSC emergence | Impacts developmental migration |
| GATA2 | Transcription factor regulating HSC gene expression | Linked to HSC function and localization |
| TIE2 | Endothelial receptor influencing HSC quiescence and migration | Niche interaction mediator |
How Is hematopoietic stem cell migration Regulated?
Hematopoietic stem cell migration is regulated by a combination of chemokine gradients, adhesion molecule turnover, and transcriptional programs. The CXCR4/CXCL12 axis is a primary regulator, with CXCL12 produced by niche cells and CXCR4 expressed on HSCs. Integrin signaling is dynamically modulated to allow detachment and re-adhesion during migration. Matrix metalloproteinases, including MMP2 and MMP9, remodel the extracellular matrix and are regulated by inflammatory cytokines. Transcription factors such as YY1 control migratory gene expression, as shown by fetal HSC migration defects in YY1-deficient mice. Niche-derived signals, including those from endothelial and perivascular cells, further tune migration in response to stress or injury.
hematopoietic stem cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCR4 | WHIM syndrome and impaired HSC mobilization | Knock-in of WHIM-associated mutations in HSC lines |
| YY1 | Fetal HSC migration and engraftment defects | Knockout mouse models and human cell lines |
| CXCL12 | Bone marrow failure and altered niche signaling | Knock-in reporters and overexpression models |
| ITGB1 | Engraftment failure and leukocyte adhesion deficiency | Point mutation knock-in in hematopoietic cells |
| MMP9 | Leukemia progression and niche remodeling | Knockout and overexpression in leukemia cell lines |
Bone marrow failure and engraftment defects
Impaired HSC migration can lead to bone marrow failure because stem cells fail to reach or repopulate the marrow niche. In transplantation settings, defective migration manifests as poor engraftment and delayed hematopoietic recovery. Studies in mouse models have shown that loss of specific transcription factors, such as YY1, disrupts fetal HSC migration and engraftment.
Leukemia and leukemic stem cell dissemination
Leukemic stem cells can exploit normal migratory pathways to disseminate and colonize extramedullary sites. The same chemokine and adhesion systems that govern HSC migration are often dysregulated in leukemia, contributing to disease progression. Understanding these mechanisms may inform therapies that block leukemic cell migration while preserving normal HSC function.
Developmental blood disorders
During embryogenesis, HSCs must migrate from the aorta-gonad-mesonephros to the fetal liver and then to bone marrow. Disruption of these migratory steps can cause developmental blood disorders and immune deficiencies. The genesis of human hematopoietic stem cells involves tightly regulated migration, and defects in this process are linked to congenital cytopenias.
From hematopoietic stem cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X control HSC migration? | CRISPR knockout in HSC-like cell lines followed by transwell migration assay |
| Does a point mutation in CXCR4 alter chemotaxis? | Point mutation knock-in in hematopoietic progenitor cells |
| Can a tagged protein track HSC migration in live cells? | Knock-in of fluorescent tag at endogenous locus |
| Does overexpression of MMP9 enhance mobilization? | Overexpression cell model in HSC lines |
| Which genes regulate engraftment? | CRISPR library screening in primary HSCs or cell lines |
| How does niche signaling affect migration? | Co-culture with endothelial or stromal cells |
How to Study the hematopoietic stem cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Directed migration toward chemokine gradient | Quantifying HSC chemotaxis after gene knockout |
| RNA-seq | Global gene expression changes | Identifying migration-associated transcriptional programs |
| Intravital microscopy | Real-time cell movement in vivo | Tracking HSC migration in bone marrow |
| Engraftment assay | Homing and repopulation capacity | Functional validation of migration genes |
| Flow cytometry | Surface marker expression and cell counts | Isolating HSC populations for migration studies |
| CRISPR library screening | Phenotypic selection of migration regulators | High-throughput discovery of novel genes |
| Proteomics | Protein abundance and interactions | Characterizing adhesion complex composition |
| Live-cell imaging | Cell motility dynamics | Assessing speed and directionality of migration |
Transwell and chemotaxis assays
Transwell migration assays measure the ability of HSCs to move toward a chemokine gradient, typically CXCL12. These assays are used to quantify migration defects after genetic perturbation. They can be combined with time-lapse imaging to assess directionality and speed.
RNA-seq and transcriptomics
RNA sequencing of HSCs before and after migration or genetic perturbation reveals gene expression programs associated with migration. Placental cell conditioned media has been shown to modify the HSC transcriptome in vitro, illustrating how environmental signals alter migratory gene expression. Differential expression analysis can identify novel regulators for follow-up.
Imaging and intravital microscopy
Intravital microscopy allows real-time visualization of HSC migration within bone marrow and other tissues. Fluorescently labeled HSCs or knock-in reporter models enable tracking of individual cells. This method provides spatial and temporal information that complements in vitro assays.
Engraftment and repopulation assays
Engraftment assays measure the ability of HSCs to home to and repopulate the bone marrow after transplantation. These assays are the functional gold standard for assessing migration and homing defects. They can be combined with genetic knockout or knock-in models to test causality.
How CRISPR Can Be Used to Study GO:0035701 hematopoietic stem cell migration
Knockout
CRISPR knockout of candidate genes in HSC-like cell lines or primary cells can test whether a gene is required for migration. For example, knockout of YY1 in mice disrupted fetal HSC migration and engraftment, demonstrating causality. Knockout screens can be combined with transwell assays to identify essential migration genes.
Point Mutation
Point mutation knock-in allows modeling of specific human variants, such as WHIM syndrome-associated CXCR4 mutations, to assess their impact on HSC migration. This approach provides allele-specific insights that knockout alone cannot reveal.
Knock-in
Knock-in of fluorescent tags or reporter genes at endogenous loci enables tracking of HSC migration in live cells and tissues. Tagged knock-in models can be used for intravital imaging and flow-based isolation of migratory populations.
Overexpression
Overexpression of migration-promoting genes, such as MMP9 or CXCR4, can enhance HSC mobilization or homing in experimental models. Overexpression studies help define sufficiency, complementing loss-of-function approaches.
How EDITGENE Supports hematopoietic stem cell migration Research
Researchers studying hematopoietic stem cell migration-related genes often need to determine whether a candidate gene is causally involved in migration, homing, or engraftment. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations to test these hypotheses.
Contact EDITGENE today to design your custom CRISPR model for hematopoietic stem cell migration research.
Frequently Asked Questions About hematopoietic stem cell migration
What is hematopoietic stem cell migration?
Hematopoietic stem cell migration (GO:0035701) is the orderly movement of a hematopoietic stem cell from one site to another, essential for blood system development and regeneration.
What genes are involved in hematopoietic stem cell migration?
Key genes include CXCR4, CXCL12, ITGB1, ITGA4, SELL, MMP2, MMP9, and the transcription factor YY1.
What is the role of CXCR4 in HSC migration?
CXCR4 is a chemokine receptor that mediates HSC retention and migration in response to CXCL12 gradients.
How is hematopoietic stem cell migration studied?
Common methods include transwell migration assays, RNA-seq, intravital microscopy, and engraftment assays.
What diseases are linked to defective HSC migration?
Defective HSC migration is linked to bone marrow failure, engraftment failure, and leukemia dissemination.
What is the GO ID for hematopoietic stem cell migration?
The GO ID is GO:0035701, under the biological_process ontology.
What is the synonym for hematopoietic stem cell migration?
The synonym is hemopoietic stem cell migration.
How does the bone marrow niche regulate HSC migration?
The niche provides chemokines, adhesion molecules, and matrix components that retain or mobilize HSCs.
Can CRISPR be used to study HSC migration?
Yes, CRISPR knockout, knock-in, and overexpression models enable causal testing of migration-related genes.
What is the role of YY1 in HSC migration?
YY1 is a chromatin factor that controls fetal HSC migration and engraftment, as shown in mouse knockout studies.
Conclusion
Hematopoietic stem cell migration (GO:0035701) is a fundamental biological process that governs the movement of HSCs during development and in adult life. It relies on chemokine gradients, adhesion molecules, and niche interactions, with key roles for CXCR4/CXCL12, integrins, and transcription factors such as YY1. Dysregulation of this process contributes to bone marrow failure, engraftment defects, and leukemia, making it a critical area for both basic and translational research. CRISPR-based models provide powerful tools to dissect the genetic control of HSC migration and to identify new therapeutic targets.
References
- 1. Pinho S et al.. 2019. Haematopoietic stem cell activity and interactions with the niche.. Nat Rev Mol Cell Biol 20(5):303-320 PMID: 30745579
- 2. Calvanese V et al.. 2023. The genesis of human hematopoietic stem cells.. Blood 142(6):519-532 PMID: 37339578
- 3. Cain TL et al.. 2025. The role of the haematopoietic stem cell niche in development and ageing.. Nat Rev Mol Cell Biol 26(1):32-50 PMID: 39256623
- 4. Harris SM et al.. 2024. Placental cell conditioned media modifies hematopoietic stem cell transcriptome invitro.. Placenta 145:117-125 PMID: 38128222
- 5. Saka S et al.. 2025. Chromatin factor YY1 controls fetal hematopoietic stem cell migration and engraftment in mice.. J Clin Invest 135(19) PMID: 40762953
- 6. Chute JP. 2006. Stem cell homing.. Curr Opin Hematol 13(6):399-406 PMID: 17053451
- 7. Miao R et al.. 2020. Hematopoietic Stem Cell Niches and Signals Controlling Immune Cell Development and Maintenance of Immunological Memory.. Front Immunol 11:600127 PMID: 33324418
- 8. Möhle R et al.. 1998. The role of endothelium in the regulation of hematopoietic stem cell migration.. Stem Cells 16 Suppl 1:159-65 PMID: 11012158
